Clinical Research Progress of NRF2 Activators in the Treatment of Age-related Diseases
Frontiers in Medical Science Research · 2021
DOI: 10.25236/fmsr.2021.030204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medical Science Research, 2021.
Abstract (Originalsprache)
Oxidation is closely related to the occurrence and development of aging and age-related diseases. NRF2 (Nuclear factor erythroid 2 related factor 2) is a key regulator of oxidative stress, which regulates the expression of antioxidant proteins, detoxification enzymes and various cytoprotective proteins. NRF2 maintains organism redox balance and genome stability, delaying the aging process and the occurrence and development of aging-related diseases. Pharmacological activators of NRF2 has been widely reported in basic research, and has performed well in clinical application research. In this article, we will focus on the latest news in basic and clinical research of NRF2 activators in age related diseases.
Zitieren
APA
(2021). Clinical Research Progress of NRF2 Activators in the Treatment of Age-related Diseases. Frontiers in Medical Science Research. https://doi.org/10.25236/fmsr.2021.030204
Vancouver
Clinical Research Progress of NRF2 Activators in the Treatment of Age-related Diseases. Frontiers in Medical Science Research. 2021. doi:10.25236/fmsr.2021.030204
BibTeX
@article{euvimed2021,
title = {Clinical Research Progress of NRF2 Activators in the Treatment of Age-related Diseases},
journal = {Frontiers in Medical Science Research},
year = {2021},
doi = {10.25236/fmsr.2021.030204}
}
EUVIMED